Skip to main content
. 2019 May 1;8(5):601. doi: 10.3390/jcm8050601
AKR1C3 Aldo-Keto Reductase Family 1 Member C3
PCa prostate cancer
CRPC castration-resistant prostate cancer
HNPC hormone-naïve prostate cancer
ADT androgen deprivation therapy
T testosterone
DHT 5α-dihydrotestosterone
AR androgen receptor
DHEA dehydroepiandrosterone
ER estrogen receptor
PG prostaglandin
TMA tissue-microarray
RP radical prostatectomy
TUR-P transurethral resection of the prostate
PFS progression-free survival
TS total score
IS intensity score
PS proportion score
GS Gleason score
CAB combined androgen blockade
DOC docetaxel
Abi abiraterone
Enz enzalutamide
LHRH luteinizing hormone-releasing hormone
ARATs androgen receptor-axis-targeted agents
GABAAR gamma-aminobutyric acid type A receptor